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Abstract
Background: Rho family GTPase regulation of the actin cytoskeleton governs a variety of cell
responses. In this report, we have analyzed the role of the GTPase Rho in maintenance of the T
lymphocyte actin cytoskeleton.
Results: Inactivation of the GTPase Rho in the human T lymphocytic cell line HPB-ALL does not
inhibit constitutively high adhesion to the integrin β1 substrate fibronectin. It did however result in
the aberrant extension of finger-like dendritic processes on the substrates VCAM-1, Fn, and mAb
specific to β1 integrins. Time-lapse video microscopy demonstrated that C3 induced extensions
were primarily the result of an altered pseudopod elongation rather than retraction. Once the
stellate pseudopodia extended, none retracted, and cells became completely immobile. Filipodial
structures were absent and the dendritic-like processes in C3 treated cells were rich in filamentous
actin. Immunolocalization of RhoA in untreated HPB-ALL cells spreading on fibronectin
demonstrated a diffuse staining pattern within the pseudopodia. In C3 treated cells, clusters of
RhoA were pronounced and localized within the altered extensions.
Conclusions: GTPase Rho is actively involved in the regulation of T lymphocyte morphology and
motility.
Background
The T lymphocyte actin cytoskeleton is clearly important
in the regulation of cell activity at a variety of different lev-
els. An intact actin cytoskeleton is required for sustained
signals leading to T cell activation [1]. T helper and cyto-
lytic effector cells reorient their intracellular components
for vectorial secretion of cytokines [2] or cytolytic compo-
nents [3] via cytoskeletal dependent mechanisms. Recent
reports suggest an active role played by the T cell cytoskel-
eton in maintaining spatially defined molecular clusters
found within the immunological synapse – a highly struc-
tured molecular array defined by contact regions between
T cells and antigen presenting cells [4–7], and reviewed in
[8,9] or NK cells and target cells [10]. Although the actin
cytoskeleton has been implicated in all these processes,
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perhaps its greatest role is in regulating T lymphocyte mo-
tility and morphology.
The first physical step in directional motility is the exten-
sion of cellular processes termed pseudopods [11]. Pseu-
dopodia are flattened, fan shape cellular protrusions
enriched in signaling molecules and cytoskeletal elements
including filamentous actin, which is preferentially nucle-
ated at the leading edge of a migrating cell [12]. A key can-
didate for regulation of the T lymphocyte actin
cytoskeleton is the GTP-binding protein Rho. This small
member of the Ras GTPase superfamily has been implicat-
ed in fibroblast models of integrin dependent actin stress
fiber formation, focal contact assembly [13], and gene in-
duction via the serum response element [14]. Studies of
Rho function have been facilitated by the use of specific
toxins such as Clostridium botulinum toxin C3 which catal-
yses the ADP-ribosylation and inactivation of Rho [15–
17]. The function of this GTPase and related family mem-
bers such as Rac and Cdc42 has been extensively studied
in the fibroblast model. In this system it has been shown
that Rho function is necessary for the production of actin
stress fibers [13]. However, in cells that are considered
highly motile and circulate through various compart-
ments of the body (such as T lymphocytes), actin stress
fibers have yet to be identified. By comparison to adherent
cells such as fibroblasts, less work has been done within
the formed elements of the blood, in particular, studies
addressing the role played by Rho in the maintenance of
T lymphocyte cytoarchitecture.
The involvement of Rho GTPases in regulating integrin
dependent events such as leukocyte homotypic aggrega-
tion and in chemokine upregulation of integrin-mediated
adhesion has recently been identified [18,19]. ADP-ribo-
sylation of Rho in neutrophils by treatment with C3 not
only inhibits cellular locomotion, but augments chemoat-
tractant induced actin polymerization [20,21]. Moreover,
inactivation of Rho in monocytic cells leads to accelerated
formation of filopodia, and it has been proposed that Rho
is a negative regulator of actin polymerization within this
cell type [22]. Active Rho is also required for normal mor-
phology, motility, and cytolytic activity of IL-2 activated
NK cells [23,24]. We and others have demonstrated the
importance of Rho in T lymphocyte activation [25,26].
Given the role played by Rho in the regulation of actin mi-
crofilaments in other cell types, and the indispensability
of a functional actin cytoskeleton in lymphocyte motility
and activation, it is of importance to study Rho's role in
the regulation of T lymphocyte integrin function and
maintenance of cytoskeletal organization.
Results
Electroporation of C3 induces complete ADP-ribosylation 
of Rho in HPB-ALL
Western blotting analysis confirmed the presence of RhoA
(~25 kDa) in the human T cell lines HPB-ALL and CEM
(Figure 1A). The bacterial toxin C3 from Clostridium botu-
linum ribosylates asparagine 41 of the small GTPase Rho
[15,16], resulting in its inactivation. C3 (25 µg/ml) was
electroporated into the T cell line HPB-ALL as described in
the Materials and Methods. After thorough washing, the
cells were incubated for 1 hour at 37°C to allow in vivo ri-
bosylation, then sonicated and lysates subjected to further
C3 ribosylation by the addition of 2 µCi [32P]-NAD and 1
µg of C3 in ribosylation buffer. By this method, any fur-
ther ADP ribosylation of Rho can be identified in vitro af-
ter in vivo ribosylation, thus serving as a measure of the
efficiency of the electroporation procedure for introduc-
ing C3 exoenzyme into HPB-ALL cells [31]. As figure 1B
demonstrates, electroporation of C3 transferase (Figure
1B, lane 3) prior to cell disruption prevented further ribo-
sylation of Rho proteins in the cell lysates. The technique
of electroporation of C3 was very efficient, as even longer
autoradiographic exposures of the gel did not demon-
strate incorporation of [32P]-NAD (data not shown). Thus
electroporation of the exoenzyme C3 fully ribosylates Rho
in vivo, to the extent that no further in vitro ribosylation of
Rho can be detected after cell lysis.
Alteration of HPB-ALL morphology by C3 exoenzyme
Inactivation of Rho did not affect the constitutively high
adhesion of HPB-ALL cells to the extracellular matrix pro-
tein fibronectin (Fn) (Figure 2). When HPB-ALL cells are
plated onto β1 integrin substrate such as fibronectin, vas-
cular cell adhesion molecule-1 (VCAM-1), or even anti-
bodies to α4β1 integrins, they respond by extending
pseudopodia and displaying a highly flattened, spread
morphology (figure 3, panels 4, 7, and 10, and ref [32]).
However, electroporation of C3 appeared to alter HPB-
ALL morphology resulting in the extension of very fine
branched finger-like cellular processes when cells were
plated on the β1 integrin substrates Fn (figure 3, panel 6),
VCAM-1 (figure 3, panel 9), or a mAb specific for β1 in-
tegrins (figure 3, panel 12). This also occurred for another
T cell line, HSB-1 (data not shown), and in activated pri-
mary T lymphocytes (Table 1). Untreated HPB-ALL, mock
electroporated control HPB-ALL, or C3 treated HPB-ALL
do not extend pseudopodia on the non-specific cell at-
tachment substrate poly-L-lysine (figure 3, panels 13–15),
demonstrating the requirement for integrin dependent
signals in both the normal spreading morphology of HBP-
ALL, and the C3 induced morphological changes in this
cell type.
RhoA immunolocalization in normal and C3 treated HPB-
ALL cells spreading on fibronectin
Immunolocalization of the GTPase RhoA was performed
to determine if inactivation by C3 exoenzyme causedBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
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spatial redistribution of RhoA in HPB-ALL. As figure 4
demonstrates, untreated HPB-ALL cells display a diffuse
staining pattern of RhoA, with small punctate microclus-
ters throughout the normal pseudopodial extensions (fig-
ure 4, left panels, arrows). Staining with secondary
antibody alone was negative (data not shown). Inactiva-
tion of Rho by electroporation of C3 exoenzyme did not
seem to cause a large overall redistribution of RhoA in
spread HPB-ALL. However, RhoA appeared to be in rela-
tively larger clusters distributed along the aberrant pseu-
dopodial structures with no diffuse staining observed
(figure 4, right panels, arrows).
Altered pseudopodia are rich in filamentous actin
The Rho family of GTPases is largely responsible for main-
tenance of cell shape in a variety of cell types, and this in-
volves regulation of the actin cytoskeleton. To localize
filamentous actin within HPB-ALL, cells adherent to
VCAM-1 were fixed and stained with TRITC-phalloidin.
Control electroporated cells display rather diffuse fila-
mentous actin staining in elongated pseudopodial proc-
esses that flatten and spread out on their termini, and
there are multiple filopodia extending from these process-
es and from the cell body (figure 5A, arrows). Cells that
had been treated with C3 exoenzyme however all contain
highly enriched filamentous actin within the extended
pseudopods. This is true on the substrates FN and anti-β1
integrin mAb (data not shown). In the C3 electroporated
cells, small filopodia extending from the cell body are ab-
sent, and multiple branched pseudopodial structures are
largely enriched in filamentous actin (Figure 5B, arrows).
Of interest, electroporation of C3 in conjunction with
FITC-labeled monomers of actin did not demonstrate in-
corporation of FITC-actin in the altered pseudopods at
early time points (data not shown), suggesting that the fil-
amentous actin in the altered pseudopods initially results
from rearrangement of pre-formed actin filaments.
Time lapse microscopy of C3 treated cells
In fibroblast models, inactivation of Rho causes retraction
of pre-formed pseudopods with a resultant deposition of
parallel tracks of thin dendritic processes [17], a pheno-
type ultimately resembling that seen in C3 treated HPB-
ALL. The phenotype induced by C3 mediated ribosylation
Figure 1
A. Western blot of RhoA protein in whole cell lysates of the T cell lines HPB-ALL and CEM. B. Electroporation of C3 efficiently 
ADP-ribosylates Rho in the T cell line HPB-ALL. Cells were untreated, electroporated in the presence of C3 (25 µg/ml), or 
electroporated in control buffer. After a 1 hr incubation at 37°C, cells were further ADP-ribosylated as described in Experi-
mental Procedures by the addition of exogenous C3 and [32P]-NAD after cell disruption.
HPB-ALL CEM
48
MW (kDa)
33
29
20
MW (kDa)
53
29
A. B.
Treatment
Electroporation
C3 (25 µg/ml)
+
--
-
+
+BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
Page 4 of 12
(page number not for citation purposes)
of Rho in HPB-ALL could result from either aberrant re-
traction of recently formed pseudopods, or altered
pseudopodial extension. These possibilities were explored
using video time-lapse microscopy. Figure 6 demonstrates
HPB-ALL spreading on VCAM-1 over a period of 1 hour,
where images from the first 10 minutes were obtained
from recorded videotape, followed by a 60 minute time
point. Untreated cells and mock electroporated cells dem-
onstrate normal HPB-ALL cell spreading (figure 6, see ar-
rows). They extend thick pseudopodia with fanned
termini, and their cell bodies are flattened and oval in
shape. The C3 induced phenotype forms at the onset of
cell spreading (figure 6, see arrows). The finger-like exten-
sions initially form from a rounded cell body and elon-
gate throughout the duration of the assay. The stellate
projections are clearly delineated even at their termini,
and the cell bodies do not demonstrate a flattened, oval,
or spindle phenotype. Thus, the C3 induced stellate phe-
notype is not primarily due to aberrant pseudopodial re-
traction, but an altered pseudopodial extension. Also of
note was the effect of C3 on the dynamic maintenance of
pseudopodia. Under normal or control electroporation
conditions, some of the VCAM-1 adherent cells would re-
tract pseudopodia, then form new extensions in different
directions. This activity was clearly inhibited in the C3
treated cells. Once the aberrant finger-like projections
were formed, no pseudopodial retraction was noted dur-
ing this time period, and the cells became completely im-
mobile. Quantification of the original movies indicate
that only 1.7% (1/60) of the C3-treated cells were motile
whereas 34.9% (45/129) of mock-electroporated cells dis-
played motility. See additional file1:C3.mov and
file2:mock.mov for the original movies.
Discussion
In the present study, we demonstrate that ADP-ribosyla-
tion of the GTPase Rho in HPB-ALL cells does not result in
a decrease in constitutively high adhesion to the extracel-
lular matrix component fibronectin. However, inactiva-
tion of Rho protein does result in the aberrant extension
of finger-like, branched dendritic projections in HBP-ALL
cells when plated on the substrates VCAM-1, fibronectin,
and mAb specific for β1 integrins. Altered pseudopodial
extension required β1 integrin signaling, as C3 treated
cells plated on the non-specific cell attachment factor
poly-L-lysine did not extend dendritic like processes. Elec-
troporation of polyclonal antibodies specific for RhoA
mimicked the C3 induced phenotype (data not shown).
The C3 induced extensions were rich in filamentous actin,
and C3 treated HPB-ALL cell bodies apparently lacked
filopodial actin microspikes, present in normal spreading
cells. Immunolocalization studies of RhoA in C3 treated
HBP-ALL cells spreading on fibronectin showed no gross
differences in RhoA distribution, however clusters of
RhoA were more delineated along the finger-like dendritic
processes of the C3 treated cells. Thus, functional Rho is
required for the proper extension and retraction of pseu-
dopods in T lymphocytes on β1 integrin substrates.
A large body of work has described the morphological
functions regulated by small GTPases of the Rho subfami-
ly. Members of this family include RhoA, RhoB, RhoC
(which are isoforms), Cdc42, G25K, RhoG, Rac1, Rac2,
and TC10 (reviewed in [34]). In fibroblast models, these
GTPases have been proposed to act in a concerted hierar-
chy to coordinately regulate distinct morphological fea-
tures. Filopodia formation of short filamentous actin
microspikes gives way to membrane ruffling and lamel-
lipodia formation, culminating in the organized produc-
tion of actin stress fibers. This has lead to the hypothesis
that small GTP binding proteins act sequentially, in the
GTPase cascade Cdc42→Rac→Rho [35]. Facilitating the
study of Rho in regulation of cell activity has been the use
Figure 2
HPB-ALL adhesion to the extracellular matrix component 
fibronectin. HPB-ALL cells were either electroporated with 
C3 (25 µg/ml) or mock electroporated and adhesion to Fn 
was compared. There was no decrease in the adhesion of C3 
treated HPB-ALL cells. The standard deviation was less than 
10%.
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Figure 3
ADP-ribosylation of Rho alters HPB-ALL spreading on β1 integrin substrates. Cells were plated on BSA (panels 1–3), Fn (pan-
els 4–6), VCAM-1 (panels 7–9), anti-β1 mAb 33B6 (panels 10–12), or poly-L-lysine (panels 13–15). HPB-ALL cells were elec-
troporated with 25 µg/ml C3 (right column), 25 µg/ml BSA (middle column), or untreated (left column). Initial magnification 
was 200 ×. Experiments in panels 1–9 and panels 10–15 were performed separately. The images are representative of at least 
four separate experiments.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
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of C3 exoenzyme, a toxin from Clostridium botulinum that
ADP-ribosylates [15,16] and inactivates Rho proteins.
Although ribosylation of other Rho family proteins such
as Rac1 can occur with C3 [33], this seemed to be very
weak [13]. In our work, C3 electroporated into the T cell
line HPB-ALL caused complete ADP-ribosylation of Rho
proteins (~25 kDa). Although Rac1 and Cdc42 were iden-
tified in western blots of whole cell lysates prepared from
the T cell lines HPB-ALL, CEM, HSB (data not shown),
and PB human T lymphocytes (data not shown), there
was no detection of ribosylation in the lower molecular
weight Rac and Cdc42 related GTPases in HPB-ALL cells,
indicating the specificity of C3.
Previous reports have demonstrated that ADP-ribosyla-
tion of B-lymphoid cell lines by C3 treatment inhibits
phorbol ester induced cellular homotypic aggregation
[18]. Also, phorbol ester and chemoattractant (IL-8 and
fMLP) induced pre-B lymphoblastoid adhesion to VCAM-
1 and neutrophil adhesion to fibrinogen was abrogated in
a dose-dependent manner by C3 exoenzyme [36]. This
may indicate that in cells of hematopoietic lineages, the
induction of an increased adhesive state may be suscepti-
ble to regulation by Rho proteins. However, we have
recently demonstrated that induced adhesion of primary
T lymphocytes to fibronectin is unaffected by Rho inacti-
vation [25], and data presented here suggests that consti-
tutively high adhesion of HPB-ALL cells to β1 integrin
substrate is unaffected by C3 treatment. Others have dem-
onstrated that inactivation of Rho in monocytes promotes
cellular adhesion to β1 integrin substrates [37]. Static cell
adhesion studies rely on a number of factors including in-
tegrin affinity regulation, integrin avidity/clustering, and
shear resistant cell shape changes. Factors affecting adhe-
sion can do so by regulating any number of these param-
eters. Thus the effects due to Rho inactivation on cell
adhesion may not only influence one or more of these pa-
rameters, but also be cell type specific even amongst the
cells of the hematopoeitic lineage.
The phenotype induced by ADP-ribosylation of Rho in T
lymphocytes appeared different than that induced in
fibroblast models, where microinjection of C3 results in
fibroblast retraction of pseudopodia, with the cell body
rounding up eventually to become non-adherent [17].
Video time-lapse microscopy demonstrated the elonga-
tion of aberrant pseudopods in HPB-ALL cells plated on
the β1 substrate VCAM-1, rather than an altered retraction
of already formed pseudopods. These results suggest an al-
tered pseudopodial extension although a defect in con-
tractibility could be involved as a secondary mechanism
for formation of aberrant processes. This phenotype also
coincided with the complete loss of cellular motility in
HPB-ALL, even though adhesion to substrate was not no-
ticeably altered. It is also important to note that normal
and C3 induced aberrant HPB-ALL spreading on Fn or
VCAM-1 is dependent on signals generated through β1 in-
tegrins, as both morphologies could be seen when un-
treated or C3 treated HPB-ALL were plated on the β1
specific mAb 33B6. When these same cells are plated on
the non-specific cell attachment factor poly-L-lysine, cells
remain round and no spreading occurs. The elongated
dendritic-like processes in C3 treated HPB-ALL cells were
F-actin rich. This phenotype caused by inactivation of Rho
is the first to be described in T lymphocytes, however, Rho
regulation of the actin cytoskeleton is not novel among
cells of the hematopoietic lineage. ADP-ribosylation of
Rho proteins in chemoattractant stimulated neutrophils
[20,21] and in both monocytic lines and fresh blood
monocytes [22,38] results in actin filament polymeriza-
tion. Although this once again highlights differences be-
tween the affects of C3 in fibroblasts and leukocytes, there
may be commonalties amongst cells that do not form dis-
tinct actin stress fibers, such as leukocytes and neuronal
cells. ADP-ribosylation of Rho proteins by C3 exoenzyme
prevents neurite retraction in the specialized growth cone
of developing neurons, and in fact promotes neurite out-
growth in the same fashion as microinjection of purified
dominant negative RhoAT19N  [39]. In these instances,
neuronal N1E-115 cell outgrowth induced by inactivation
of RhoA was mimicked by microinjection of Rac1- or
Cdc42-GST fusion proteins, and could be abolished by
coinjection of dominant negative Cdc42T17N or Rac1T17N
[39]. From these results, the authors concluded that
inactivation of RhoA by C3 exoenzyme treatment resulted
in the activation of Rac1 and Cdc42 GTPases, suggesting
Table 1: Morphology of PMA + ionomycin activated primary T lymphocytes. Data represent averages and standard deviation from 3 
separate experiments, and are expressed as the percentage of adherent cells demonstrating pseudopodia. All of the pseudopods 
observed were of the C3 phenotype.
Integrin Substrate Percent of adherent cells with aberrant morphology
mAb 33B6 40.3 +/- 9.4
Fn 38.1 +/- 7.4
VCAM-1 41.0 +/- 6.8BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
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the mutually exclusive function of RhoA and Rac1/Cdc42.
Cdc42 has been implicated in the formation of small, ac-
tin-rich filopodia [34], which are similar to those seen on
spread HPB-ALL cells (figure 5) around the periphery of
the cell body and extended pseudopods. After C3 electro-
poration, HPB-ALL were allowed to spread on VCAM-1
for 1 hour, and TRITC-phalloidin staining demonstrated
the complete absence of fine filopodial structures. Given
Figure 4
Punctate staining pattern of RhoA in untreated and C3 treated HPB-ALL cells. Cells were stained for RhoA as described in the 
Material and Methods. Untreated cells are in the left panels, and C3 treated cells are represented in the right panels. Arrows 
indicate punctate patterns of RhoA in HPB-ALL cells spreading on the extracellular matrix component fibronectin.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
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the morphologic similarity between neurite outgrowth of
N1E-115 cells and the aberrant pseudopodial extension of
HPB-ALL when RhoA is inhibited with C3 exoenzyme, it
will be interesting to determine if other GTPases such as
Rac or Cdc42 are activated to promote this phenotype af-
ter C3 treatment of HPB-ALL cells. The thick actin rich
stellate projections emanating from the cell body of C3
electroporated HPB-ALL may be the result of condensa-
tion of filopodia, where Cdc42 may be induced into a
highly active state. Actin filament elongation would con-
tinue and RhoA dependent retraction of filamentous actin
would be abrogated. This could occur by the release of
limited effector molecules shared between the two GTPas-
es, possibilities that are currently under investigation.
The immunolocalization of RhoA in normal and C3 treat-
ed cells did not appear drastically different in that RhoA
was apparent in both normal and aberrant pseudopodial
extensions. The notable exception was that clusters of
RhoA appeared less diffuse in the altered pseudopods of
C3 treated cells (figure 6). Although ADP-ribosylation of
Rho does not significantly alter the subcellular distribu-
tion of RhoA, Rho activity is inhibited. This is thought to
prevent activation of downstream Rho targets required for
normal integrin dependent morphological changes. A
number of potential downstream Rho effector molecules
have been identified recently. These include p150 RhoA-
binding kinase α and β (p150 ROKα and β) [40,41], p160
Rho-associated coiled-coil containing protein kinase
(Rho-p160ROCK) [42], p164 Rho kinase [43], p120 pro-
tein kinase N (p120 PKN) [44,45], and PKC-related ki-
nase-2 (PRK-2) [46]. These kinases specifically bind to the
GTP bound form of Rho, except for PRK-2, which can
bind both Rho and Rac GTPases. Interestingly, inhibition
of Rho-p160ROCK has recently been shown to give simi-
lar lymphocyte morphology as inhibition of Rho with C3
[50]. Another interesting candidate may be p120 PKN, as
recent studies have established that PKN phosphorylates
cytoskeletal intermediate filaments [47] and is directly
linked to the cytoskeletal network through associations
with α-actinin [48]. Also, PKN may be involved in relating
cytoplasmic signals to the nucleus, for in response to
stress, nuclear translocation of PKN occurs [49]. This is
particularly important in light of previous work demon-
strating that inactivation of Rho in peripheral blood T
lymphocytes inhibits costimulatory signals up-regulating
IL-2 production [25]. Future experiments will focus on de-
termining the relationship of Rho GTPases and the regu-
lation of T cell morphology [25,51,52].
Conclusions
Inactivation of Rho results in an active elongation of actin
rich, finger-like dendritic processes dependent on β1 in-
tegrin signaling. Thus Rho activity is required for T lym-
phocyte spreading morphologies, and is required for T
lymphocyte motility. In static cell adhesion assays, how-
ever, Rho activity is not required to maintain constitutive-
ly high levels of adhesion to fibronectin. Further study of
Rho and it's related GTPases and downstream effector
molecules, will be important in elucidating mechanisms
Figure 5
TRITC-phalloidin staining demonstrates that altered pseudopodia are enriched for filamentous actin. Cells were electropo-
rated with control buffer (A), or electroporated with C3 (25 µg/ml, B, C) and plated on VCAM-1 that had been immobilized on 
glass coverslips.
A BBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
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regulating the lymphocyte cytoskeleton and thus T cell
function.
Materials and Methods
Reagents
Poly-L-lysine was purchased from Sigma Chemical Co.
(St. Louis, MO). Fn was affinity purified from 200 ml of
human plasma (Gulf Coast Regional Blood Center, Hou-
ston, TX). Briefly, gelatin-conjugated sepharose bead
columns were pre-washed with PBS containing 2 mM
EDTA and 0.1 mM PMSF. After washing, plasma contain-
ing 2 mM EDTA and 0.1 mM PMSF was passed over the
column twice, then washed with at least 4 volumes of
PBS/EDTA/PMSF. Elution of FN from the columns was
Figure 6
Video time lapse microscopy demonstrates that the morphologically distinct HPB-ALL pseudopodia are due to aberrant exten-
sion, rather than aberrant pseudopodial retraction. Cells were "untreated," subjected to electroporation in control buffer 
("mock electroporated"), or electroporated in the presence of C3 (25 µg/ml, "C3 electroporated"). Cells were then plated 
onto VCAM-1 and let spread for 1 hr (as described in Materials and Methods) while being recorded by a CCD camera and time 
lapse VCR. Numbers in lower left corners of images denote time elapsed in minutes. Arrowheads identify pseudopodia of 
spreading cells. Initial magnification was 400×.
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performed with 4 M urea in 0.15 M NaCl, 2 mM EDTA,
0.1 mM PMSF, 20 mM Tris-HCl, pH 8.0. Collected frac-
tions were dialyzed in PBS. All procedures were carried
out at RT. Fn purity was determined by SDS-PAGE. VCAM-
1 was provided by Dr. S. Fong (Genentech, San Francisco,
CA). C3 exoenzyme was purified as previously described
[25]. Anti-β1 integrin mAb 33B6 and anti α4β1 integrin
mAb 19H8 were generated in this laboratory and have
been previously described [27,28]. Rabbit polyclonal anti-
Cdc42, -Rac1, -Rac2, -RhoA, and mouse monoclonal anti-
Ras, were purchased from Santa Cruz Biotechnology (San-
ta Cruz, CA).
Cells
The T cell lines HPB-ALL and CEM were maintained in
complete media (RPMI-1640 supplemented with 10%
FBS; 10 U/ml of both penicillin and streptomycin; and 1
mM L-Glutamine, all from Life Technologies, Grand Is-
land, NY). Freshly isolated peripheral blood T cells were
purified and activated by cross-linking CD28 and CD3 as
previously described [29].
Time Lapse and Fluorescence Microscopy
HPB-ALL cells were plated on VCAM-1 in the temperature
controlled environment of an inverted Nikon (Melville,
NY) Diaphot-TMD microscope for 1 hour. During this
time, images were obtained through an Optronics
(Galeto, CA) VI-470 CCD camera and recorded by time-
lapse cinematography on a Panasonic (Secaucus, NJ)
sVHS AG-6730 time-lapse videocassette recorder. Record-
ings were played back and digitized on a Macintosh IIVX
computer equipped with a Data Translation (Marlboro,
MA) Frame Grabber card using NIH IMAGE software
(available from ftp://codon.nih.gov/pub/nih-image/nih-
image161_fat.hqx).
For fluorescence microscopy, glass coverslips were coated
with Fn (10 µg/ml), VCAM-1 (5 µg/ml) or mAb 19H8 (0.5
µg/ml) for at least 2 hours at 37°C in 50 mM Tris (pH
9.5). Coverslips were blocked with BSA (1% w/v in PBS)
for 30 min at room temperature then washed with PBS.
HPB-ALL cells were then plated onto the coverslips and
incubated for 1 hour at 37°C in complete media. The cells
were then washed on the coverslips, and fixed with 2%
paraformaldehyde for at least 30 min at 4°C. A solution
of 0.1% TritonX-100 was then used to permeabilize the
cells by treatment for 10 min at 4°C. After permeabiliza-
tion, coverslips were again blocked with 1% BSA. After
washing in PBS, 80 µM phalloidin-TRITC or 1 µg/ml anti-
RhoA antibody was incubated for 30 min at 4°C. Cells
were visualized on a Nikon DIAPHOT-TMD inverted mi-
croscope and images were digitized as described above.
Western Blotting
All western blotting steps were carried out at 4°C for at
least 2 hours. Cell lysates from approximately 2 × 106 cell
equivalents were subjected to 12.5% SDS-PAGE, trans-
ferred onto PVDF membranes (Bio-rad, Richmond, CA),
then blocked with 5% BSA and 5% non-fat milk. Mem-
branes were extensively washed, then incubated with the
primary (0.5 µg/ml) polyclonal anti-RhoA. After washing,
membranes were incubated with Goat anti-rabbit poly-
clonal antibody conjugated to HRP (Cappel, Durham,
NC). Chemiluminescence was performed as described by
the manufacturer (Pierce, Rockford, IL).
Cell Adhesion Assays
Adhesion assays were performed in modified Tyrodes
buffer [30] composed of 12 mM NaHCO3 (pH 7.4), 150
mM NaCl, 2.5 mM KCl, 2 mM MgCl2, 1 mg/ml BSA, and
1 mg/ml glucose. Plates were pre-coated with Fn (10 µg/
ml) for at least 2 hours at RT in 0.1 M NaHCO3. BSA (2%
w/v) was then added to block unbound sites. Cells were
resuspended in modified Tyrodes buffer. After the cells
were added to the washed plates in 100 µl of modified ty-
rodes (1 × 105 cells), plates were spun at 300 rpm for 5
min, then incubated for 45 min at 37°C and 5% CO2.
Two images were digitized (see above) from each well be-
fore washing, then plates were carefully washed 4 × with
pre-warmed (37°C) modified Tyrodes buffer. After wash-
ing, images from the same position were digitized. Cell
numbers were quantitated using NIH Image software, and
adhesion assays are graphed as the percentage of input
cells remaining after washing.
Electroporation of C3 into HPB-ALL cells
HPB-ALL cells were washed in RPMI-1640 and resuspend-
ed between 1–2 × 106 cells per 100 µl RPMI-1640. Control
cells were electroporated with the indicated control buff-
ers. Cell samples were placed into pre-chilled (4°C) 4 mm
or 1 mm electroporation cuvettes (BTX Inc., San Diego,
CA) and electroporated under the following conditions:
500 V/capacitance and resistance, 1250 µF capacitance
timing, 720 ohms resistance, and 270 V for 4 mm gap cu-
vettes or 68 V for 1 mm gap cuvettes (field strength of
~700 Vcm-1). Both antibodies and C3 were electroporated
at a final concentration of 25 µg/ml, incubated on ice for
5 min, then washed with complete media at room tem-
perature and used for assays. Control buffer for electropo-
ration of C3 consisted of the buffers used in the
purification of C3, including the appropriate concentra-
tion of bovine α-thrombin [25]. All electroporation of
proteins were carried out on an Electro Cell Manipulator
600 (BTX Inc.). This procedure had previously been opti-
mized for intracellular incorporation of macromolecules
by electroporation of goat anti-mouse FITC conjugated
antibodies. Electroporation efficiency during theBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/2
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optimization procedure was monitored by FACS analysis
and fluorescence imaging (data not shown).
C3 Ribosylation
Purified C3 or BSA control were electroporated at a con-
centration of 25 µg/ml. After electroporation, cells were
transferred into 1.5 ml eppendorf tubes and incubated for
1 hr at 37°C to allow ribosylation. Cells were then washed
extensively in 1% BSA/PBS to remove any C3 not incorpo-
rated into the cells. Next, the cells were resuspended at 3
× 106 cells/ml in ice cold sonication buffer (250 mM su-
crose; 10 mM HEPES, pH 7.4; 1 mM EDTA; 5 mM MgCl2;
1 mM DTT; 0.1 mM GTP; 1 µg/ml leupeptin, 1 µg/ml pep-
statin A, and 1 µg/ml aprotinin; 1 mM PMSF) and sonicat-
ed for 10 seconds. After sonication with a Sonic
Dismembrator Model 300 with microtip (Fisher), 100 µl
of the mixture was added to 50 µl of 3 × reaction buffer
containing 150 mM Tris-HCl, pH 8.0; 30 mM thymidine;
3 mM DTT; 5 mM MgCl2, 0.3 mM GTP. To this mixture,
1.0 µg purified C3 and 2 µCi [32P]-NAD (NEN-Dupont,
Boston, MA) were added. After incubation for 1 hr at
37°C, SDS was added to 2% final w/v and this mixture
was immersed in a boiling water bath for 10 min. Eight
volumes of ice cold ethanol was then added, and these
samples were kept at -20°C for at least 1 hr. Precipitated
proteins were pelleted, and dissolved in SDS-PAGE sam-
ple buffer by boiling for 10 min. Samples were then sub-
jected to 12.5% SDS-PAGE and analyzed by
autoradiography.
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